What should GPs be doing about chaperones?
نویسندگان
چکیده
منابع مشابه
What should WHO be doing about patient safety and technology?
INTRODUCTION Technology has promised a great deal as a tool for potentially reducing harm in healthcare, but has frequently failed to deliver. It can present risks to patients if used incorrectly. Technology can also mitigate against risk by reducing error through improved design of processes or equipment. Technology is an important thread running through many areas of patient safety: reporting...
متن کاملIgA deficiency: what we should-or should not-be doing.
Although IgA deficiency (IgAD) is currently recognised as the most frequent immunodeficiency in humans, individuals with IgAD are largely considered to be healthy and when discovered are usually not investigated further or followed up. The rare occasion when IgAD is a cause for concern is when these individuals require blood or blood products, in which case current practice advises that product...
متن کاملI-14: Assisted Reproduction and Religion What Consideration Should Be and Should Not Be Relevant,
Several important issues are pertinent to an ethical discussion of the new technology today grouped under the name Assisted Reproduction Technology (ART). This is a moral imperative because each of us must decide what is to be considered ethically acceptable in assisted reproduction. Reflecting on the ethical dimension of ‘creating’ a new human life can play a major role in ensuring that in eac...
متن کاملWhat should we be doing about fungal infections in intensive care?
The Surviving Sepsis Campaign guidelines recommend that empiric antifungal therapy is given to intensive care unit (ICU) patients when deemed warranted; it should be tailored to the local pattern of the most prevalent Candida species (Candida spp.), and account for any prior administration of azoles drugs. In a recent issue of the British Journal of Anaesthesia, Chalmers and Bal reported the re...
متن کاملGenetic testing in epilepsy: what should you be doing?
With the burgeoning array of molecular tests available in the epilepsies, the clinician needs to know which tests to order for each patient. Epileptic encephalopathies are the most important clinical group for genetic testing with an increasing number of distinctive epilepsy syndromes being recognized. Identification of the causative mutation affects treatment as well as prognostic and genetic ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: British Journal of General Practice
سال: 2014
ISSN: 0960-1643,1478-5242
DOI: 10.3399/bjgp14x682489